Table 2.
Differences between the control and experimental group in terms of the efficacy variables at baseline (pre-intervention).
| Basal Response Variables | Groups | |||
|---|---|---|---|---|
| All Patients n = 52 (100%) |
Control n = 22 (42.31%) |
Experimental n = 30 (57.69%) |
p-Value | |
| WOMAC | ||||
| General | 8.40 (3.03) | 7.82 (1.82) | 8.83 (3.65) | 0.57 |
| Stiffness | 3.27 (1.30) | 3.77 (1.11) | 2.90 (1.32) | 0.02 |
| Functional capacity | 27.67 (8.53) | 27.32 (7.21) | 27.93 (9.49) | 0.91 |
| Lattinen | ||||
| General | 12.06 (3.30) | 12.09 (3.28) | 12.03 (3.38) | 0.72 |
| Intensity | 2.50 (0.90) | 2.59 (0.96) | 2.43 (0.86) | 0.7 |
| Frequency | 2.83 (0.90) | 2.77 (0.92) | 2.87 (0.90) | 0.79 |
| Analgesics | 2.12 (0.83) | 1.91 (0.81) | 2.27 (0.83) | 0.11 |
| lncapacity | 1.94 (0.64) | 2.00 (0.62) | 1.90 (0.66) | 0.58 |
| Pain induced insomnia | 2.46 (1.31) | 2.68 (1.25) | 2.30 (1.34) | 0.27 |
| EuroQoL | 9.25 (1.68) | 9.50 (1.85) | 9.07 (1.55) | 0.4 |
| HAQ | 1.28 (0.51) | 1.38 (0.47) | 1.21 (0.54) | 0.14 |
| Yesavage depression | 1.63 (1.60) | 1.55 (1.30) | 1.70 (1.80) | 0.93 |
| Baseline Session 1 VAS | 4.98 (2.54) | 4.89 (2.95) | 5.04 (2.31) | 0.94 |
Average (and standard deviation) shown. Differences were assessed using the Mann-Whitney test and by calculating the corresponding p-value. WOMAC: Western Ontario and McMaster Universities Osteoarthritis Index; HAQ: Health Assessment Questionnaire; VAS: Visual Analog Scale.